Introduction Managing weight while navigating chronic digestive issues can feel like a delicate balancing act
instead, the multisystem pathologic processes that are associated with this condition have long been well established as drivers of its clinical presentation and outcomes
Haywood CJ, Prendergast LA, Lim R, Lappas M, Lim WK, Proietto J
One potential strategy involves engineering brain-targeted NPs designed to release exenatide within the initial 72 h post-stroke, with the aim of achieving optimal neuroprotection [304306]
Although the FDA has issued industry guidance on 503A compounding, detailing what it perceives to be essentially a copy, this guidance falls short of establishing legally enforceable responsibilities for compounders